Sunesis Pharmaceuticals (SNSS) - Management Comments

Sunesis Pharmaceuticals (SNSS) – Management Comments

Jul 7, 2020 04:02 PM Sunesis Pharmaceuticals (SNSS) reduces workforce to focus on development of PDK1 inhibitor, SNS-510
Jun 23, 2020 07:32 AM Sunesis Pharmaceuticals (SNSS) will not advance its non-covalent BTK inhibitor vecabrutinib into planned Phase 2 portion of Phase 1b/2 trial in CLL
Sep 19, 2019 07:05 AM
Jun 17, 2019 05:51 AM
Mar 7, 2019 04:26 PM
Jan 2, 2019 07:02 AM
Dec 3, 2018 06:01 AM
Jun 25, 2018 04:11 PM
Dec 4, 2017 04:12 PM
Nov 30, 2017 07:03 AM
Jun 23, 2017 07:11 AM
May 1, 2017 04:36 PM
Mar 22, 2017 07:12 AM
Jan 23, 2017 07:04 AM
Oct 13, 2016 04:06 PM
Jun 13, 2016 07:04 AM
May 5, 2016 09:11 AM
Mar 23, 2016 07:09 AM
Jan 4, 2016 07:03 AM
Dec 8, 2015 07:16 AM
Dec 1, 2015 07:04 AM
Oct 7, 2015 04:03 PM
Jul 23, 2015 04:22 PM
Jun 12, 2015 07:06 AM
Dec 8, 2014 01:32 PM
Dec 8, 2014 08:46 AM
Nov 24, 2014 07:05 AM
Nov 19, 2014 07:04 AM
Nov 17, 2014 09:08 AM
Oct 6, 2014 06:33 AM
Aug 5, 2014 07:07 AM
Jul 9, 2014 07:06 AM
Dec 10, 2013 07:17 AM
Sep 25, 2013 09:30 AM